Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Synthesis and in vitro transdermal penetration of methoxypoly(ethylene glycol) carbonate derivatives of stavudine.

N'Da DD, Breytenbach JC, Legoabe LJ, Breytenbach JW.

Med Chem. 2009 Nov;5(6):497-506.

PMID:
19673696
2.

Synthesis of methoxypoly(ethylene glycol) carbonate prodrugs of zidovudine and penetration through human skin in vitro.

N'da DD, Breytenbach JC.

J Pharm Pharmacol. 2009 Jun;61(6):721-31. doi: 10.1211/jpp.61.06.0004.

PMID:
19505362
3.

Synthesis and in vitro transdermal penetration of methoxypoly(ethylene glycol) carbonate and carbamate derivatives of lamivudine (3TC).

van Heerden J, Breytenbach JC, N'Da DD, Breytenbach JW, du Preez JL.

Med Chem. 2010 Mar;6(2):91-9.

PMID:
20158460
4.

Synthesis and in vitro human skin penetration of oligo- and polymeric ethylene glycol carbonates of zidovudine and stavudine.

N'Da DD, Breytenbach JC, Breytenbach JW.

Arzneimittelforschung. 2010;60(9):575-82. doi: 10.1055/s-0031-1296328.

PMID:
21117502
5.

Synthesis and transdermal penetration of stavudine-5'-esters.

Holmes EM, Breytenbach JC, Gerber M, du Plessis J.

Med Chem. 2010 Sep;6(5):271-6.

PMID:
20977413
6.

Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.

Aboofazeli R, Zia H, Needham TE.

Drug Deliv. 2002 Oct-Dec;9(4):239-47.

PMID:
12511202
7.
8.

Synthesis, nanosizing and in vitro drug release of a novel anti-HIV polymeric prodrug: chitosan-O-isopropyl-5'-O-d4T monophosphate conjugate.

Yang L, Chen L, Zeng R, Li C, Qiao R, Hu L, Li Z.

Bioorg Med Chem. 2010 Jan 1;18(1):117-23. doi: 10.1016/j.bmc.2009.11.013. Epub 2009 Nov 10.

PMID:
19959368
9.
10.

Transdermal delivery of atenolol: effect of prodrugs and iontophoresis.

Anroop B, Ghosh B, Parcha V, Khanam J.

Curr Drug Deliv. 2009 Jul;6(3):280-90.

PMID:
19604142
11.

Study of different substituted cyclic and acyclic benzylpronucleotides of d4T relative to their hydrolytic stability and antiviral activity.

Muus U, De Clercq E, Balzarini J, Naesens L, Meier C.

Nucleosides Nucleotides Nucleic Acids. 2003 May-Aug;22(5-8):791-5.

PMID:
14565280
12.

Synthesis and transdermal permeation of novel N4-methoxypoly(ethylene glycol) carbamates of cytarabine.

Legoabe LJ, N'Da DD, Breytenbach JC, du Preez JL, du Plessis J.

Drug Dev Ind Pharm. 2010 Dec;36(12):1477-85. doi: 10.3109/03639045.2010.488646. Epub 2010 Jun 19.

PMID:
20560790
13.

Piperazinylalkyl prodrugs of naproxen improve in vitro skin permeation.

Rautio J, Nevalainen T, Taipale H, Vepsäläinen J, Gynther J, Laine K, Järvinen T.

Eur J Pharm Sci. 2000 Aug;11(2):157-63.

PMID:
10915963
14.

Design and synthesis of lipophilic phosphoramidate d4T-MP prodrugs expressing high potency against HIV in cell culture: structural determinants for in vitro activity and QSAR.

Siddiqui AQ, McGuigan C, Ballatore C, Zuccotto F, Gilbert IH, De Clercq E, Balzarini J.

J Med Chem. 1999 Oct 7;42(20):4122-8.

PMID:
10514282
15.

Transdermal penetration of cytarabine and its 5'-O alkyl ester derivatives.

Legoabe LJ, Breytenbach JC, N'Da DD, Breytenbach JW.

Med Chem. 2010 Mar;6(2):108-13.

PMID:
20218966
17.

Synthesis of piperazinylalkyl ester prodrugs of ketorolac and their in vitro evaluation for transdermal delivery.

Qandil A, Al-Nabulsi S, Al-Taani B, Tashtoush B.

Drug Dev Ind Pharm. 2008 Oct;34(10):1054-63. doi: 10.1080/03639040801946681 .

PMID:
18608464
18.

Human skin permeation of branched-chain 3-0-alkyl ester and carbonate prodrugs of naltrexone.

Vaddi HK, Hamad MO, Chen J, Banks SL, Crooks PA, Stinchcomb AL.

Pharm Res. 2005 May;22(5):758-65. Epub 2005 May 17.

PMID:
15906171
19.

Synthesis and biological evaluation of fatty acyl ester derivatives of 2',3'-didehydro-2',3'-dideoxythymidine.

Agarwal HK, Loethan K, Mandal D, Doncel GF, Parang K.

Bioorg Med Chem Lett. 2011 Apr 1;21(7):1917-21. doi: 10.1016/j.bmcl.2011.02.070. Epub 2011 Feb 18.

PMID:
21382714
20.

Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers.

Cho YA, Gwak HS.

Drug Dev Ind Pharm. 2004 Jul;30(6):557-64.

PMID:
15285328

Supplemental Content

Support Center